SCHEMBL631275

SCHEMBL631275

C=CCOC(CCC)OCC=C

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TSHR P16473 3/20 0.33
POLB P06746 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11246030 0.86 TSHR (0.39) MEN1KMT2ATSHRALDH1A1
SCHEMBL2900803 0.84 TSHR (0.40) MEN1KMT2ATSHRALDH1A1
SCHEMBL454872 0.82 TSHR (0.43) TSHRALDH1A1
SCHEMBL2334470 0.80 ALDH1A1 (0.49) TSHRALDH1A1
SCHEMBL14137863 0.80 MEN1 (0.34) MEN1KMT2ATSHRPOLBALDH1A1
SCHEMBL9764014 0.79 CA1 (0.30)
SCHEMBL5303308 0.79 MEN1 (0.40) MEN1KMT2ATSHRPOLB
SCHEMBL25401339 0.79 CA1 (0.33) TSHRALDH1A1
SCHEMBL11552069 0.79 TSHR (0.38) TSHRPOLBALDH1A1
SCHEMBL9448501 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116064016-B Scale inhibition anti-swelling shrinkage swelling agent and preparation method and application thereof 中国石油化工股份有限公司 2024-04-05 CN claimed
EP-4321561-A1 PREPARATION METHOD OF SUPER ABSORBENT POLYMER AND SUPER ABSORBENT POLYMER LG Chem, Ltd. (KR) 2024-02-14 EP claimed
CN-110746527-B Treatment method of (methyl) acrylic acid wastewater 四川大学 2023-05-16 CN claimed
WO-2022265475-A1 PREPARATION METHOD OF SUPER ABSORBENT POLYMER AND SUPER ABSORBENT POLYMER 주식회사 엘지화학 2022-12-22 WO claimed
CN-110527486-A Resistance to ultraviolet organosilicon adhesive of one kind and preparation method thereof DING AISHUN 2019-12-03 CN claimed
EP-3194452-B1 ENANTIOPURE OR ENANTIOENRICHED BDDE AND ITS USE AS CROSSLINKING AGENT IN THE MANUFACTURE OF CROSS-LINKED PRODUCTS GALDERMA SA (CH) 2018-06-13 EP claimed
CN-107674639-A A kind of preparation method of organosilicon adhesive 复旦大学 2018-02-09 CN claimed
EP-3194452-A1 ENANTIOPURE OR ENANTIOENRICHED BDDE AND ITS USE AS CROSSLINKING AGENT IN THE MANUFACTURE OF CROSS-LINKED PRODUCTS Galderma S.A. (CH) 2017-07-26 EP claimed
CN-106118584-A Cold curing high transmission rate organosilicon adhesive and preparation method thereof 复旦大学 2016-11-16 CN claimed
WO-2016030516-A1 ENANTIOPURE OR ENANTIOENRICHED BDDE AND ITS USE AS CROSSLINKING AGENT IN THE MANUFACTURE OF CROSS-LINKED PRODUCTS GALDERMA S.A. (CH) 2016-03-03 WO claimed
US-5225473-A For bioelectrodes MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-07-06 US claimed
US-4873299-A Batchwise preparation of crosslinked, finely divided polymers BASF AKTIENGESELLSCHAFT (DE) 1989-10-10 US claimed
EP-0238050-B1 PROCESS FOR DISCONTINUALLY PREPARING FINE PARTICLES OF CURED POLYMERS BASF Aktiengesellschaft (DE) 1989-10-04 EP claimed
US-12338210-B2 Degradable polymers and monomers therefor THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2025-06-24 US disclosed
WO-2024136394-A1 PREPARATION METHOD OF SUPER ABSORBENT POLYMER 주식회사 엘지화학 2024-06-27 WO disclosed
WO-2024134671-A1 PREPARATION OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE BHISAJ PHARMACEUTICALS PVT LTD (IN) 2024-06-27 WO disclosed
EP-0319829-A2 Optical material KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1989-06-14 EP disclosed
EP-0318183-A2 Pressure-sensitive medical sealant MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-05-31 EP disclosed
US-4242255-A ETHYLENEBIS/SALICYLIDENEIMINATO/IRON II AKZONA INCORPORATED (US) 1980-12-30 US disclosed
EP-0006644-A2 Fire retardant, curable, ethylenically unsaturated compositions and shaped articles prepared from these compositions AKZO N.V. (NL) 1980-01-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12338210-B2 Degradable polymers and monomers therefor HDHD5, LTA4H, KYNU MEN1 179/4885KMT2A 299/4885TSHR 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.